ADVIA CENTAUR XP CORTISOL (COR) ASSAY N/A 10309078

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2016-12-15 for ADVIA CENTAUR XP CORTISOL (COR) ASSAY N/A 10309078 manufactured by Siemens Healthcare Diagnostics, Inc..

Event Text Entries

[62804051] The cause for the falsely elevated advia centaur xp cortisol patient result is unknown. Siemens is investigating the incident. The instruction for use under the interpretation of results section states the following: "results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings. "
Patient Sequence No: 1, Text Type: N, H10


[62804054] Falsely elevated advia centaur xp cortisol patient results were reported by the customer, and considered discordant compared to the lower alternate cortisol test method results. The advia centaur xp cortisol result indicated an adequate response to synacthen stimulation, and there was a delay in the patient receiving hydrocortisone replacement treatment. There was no report of adverse health consequences due to the discordant advia centaur xp cortisol result or delayed treatment.
Patient Sequence No: 1, Text Type: D, B5


[68217711] Siemens filed the initial mdr 1219913-2016-00245 on 12/02/2016 for falsely elevated advia centaur xp cortisol patient results. 01/26/2017 - additional information: the patient was not taking any medication prior to testing, and has subsequently been started on hydrocortisone. The patient samples were collected on (b)(6) 2016, referred to another laboratory for 17-hydroxyprogesterone analysis, and cortisol was inadvertently measured on each sample. Based on the difference of the cortisol results between the advia centaur xp and the alternate test method (#1), the samples were sent out to another laboratory test method (#2) for further confirmation. Note: the cortisol results from alternate test method (#1), and alternate test method (#2) were reported in mdr 1219913-2016-00245. Baseline patient results prior to the synacthen test. Time (minutes): 0 , 30, 60; cortisol results (nmol/l): 254, 453, 470. Other laboratory findings: urine steroid profile has confirmed 11-hydroxylase deficiency (incomplete as cortisol metabolites are present too). Siemens continues to investigate.
Patient Sequence No: 1, Text Type: N, H10


[75950302] Siemens filed the initial mdr 1219913-2016-00245 on 12/02/2016 for falsely elevated advia centaur xp cortisol patient result and mdr 1219913-2016-00245 supplemental report 1 filed on 02/07/2017 for additional information. On 04/26/2017 - additional information: based on confirmed 11- hydroxylase deficiency, there is sufficient literature that documents that a consequence of the lack of 11-hydroxylase activity leads to the accumulation of metabolic intermediates like 11-deoxycortisol, which is listed in the instruction for use (ifu) as a potentially cross-reactive substance in the advia centaur xp cortisol assay. It is therefore very likely that the discordant results, with the roche cobas gen ii assay, and the lc/ms-ms are due to cross-reactivity due to accumulation of 11-deoxy-cortisol. The instruction for use under the interpretation of results section states the following: "results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings. " the instrument is performing within specifications. No further device evaluation is required.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1219913-2016-00245
MDR Report Key6177254
Date Received2016-12-15
Date of Report2017-05-16
Date of Event2016-11-09
Date Mfgr Received2017-04-26
Device Manufacturer Date2016-04-07
Date Added to Maude2016-12-15
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. STEPHEN PERRY
Manufacturer Street333 CONEY STREET
Manufacturer CityEAST WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal02032
Manufacturer Phone5086604163
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Street333 CONEY STREET
Manufacturer CityEAST WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal Code02032
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameADVIA CENTAUR XP CORTISOL (COR) ASSAY
Generic NameCORTISOL IMMUNOASSAY
Product CodeJFT
Date Received2016-12-15
Model NumberN/A
Catalog Number10309078
Lot Number019308
Device Expiration Date2017-07-07
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer AddressTARRYTOWN NY 10591 US 10591


Patients

Patient NumberTreatmentOutcomeDate
10 2016-12-15

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.